EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

The risk of delirium after sedation with propofol or midazolam in intensive care unit patients

Thomas G van Gelder iD, Irene J van Diem-Zaal, Sandra M A Dijkstra-Kersten, Nikki de Mul, Arief Lalmohamed, Arjen J C Slooter

British Journal of Clinical Pharmacology · 2024

DOI: 10.1111/bcp.16031 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Thomas G van Gelder und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Midazolam, Propofol, Intensive Care Units, Hypnotics and Sedatives. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Society, Chartered Society of Forensic Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Knowledge of risk factors may provide strategies to reduce the high burden of delirium in intensive care unit (ICU) patients. We aimed to compare the risk of delirium after deep sedation with propofol versus midazolam in ICU patients.

Methods

In this prospective cohort study, ICU patients who were in an unarousable state for ≥24 h due to continuous sedation with propofol and/or midazolam were included. Patients admitted ≤24 h, those with an acute neurological disorder and those receiving palliative sedation were excluded. ICU patients were assessed daily for delirium during the 7 days following an unarousable state due to continuous sedation.

Results

Among 950 included patients, 605 (64%) subjects were delirious during the 7 days after awaking. The proportion of subsequent delirium was higher after midazolam sedation (152/207 [73%] patients) and after both propofol and midazolam sedation (257/377 [68%] patients), compared to propofol sedation only (196/366 [54%] patients). Midazolam sedation (adjusted cause‐specific hazard ratio [adj. cause‐specific HR] 1.32, 95% confidence interval [CI] 1.05‐1.66) and propofol and midazolam sedation (adj. cause‐specific HR 1.29, 95% CI 1.06‐1.56) were associated with a higher risk of subsequent delirium compared to propofol sedation only.

Conclusion

This study among sedated ICU patients suggests that, compared to propofol sedation, midazolam sedation is associated with a higher risk of subsequent delirium. This risk seems more apparent in patients with high cumulative midazolam intravenous doses. Our findings underpin the recommendations of the Society of Critical Care Medicine Pain, Agitation/sedation, Delirium, Immobility (rehabilitation/mobilization), and Sleep (disruption) guidelines to use propofol over benzodiazepines for sedation in ICU patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MidazolamPropofolIntensive Care UnitsHypnotics and SedativesDeliriumDeep SedationHumansMaleFemaleMiddle AgedProspective StudiesAgedRisk FactorsAdult

Stichwörter der Autor:innen

critical caredeep sedationdeliriumintensive care units

Substanzen

MidazolamPropofolHypnotics and Sedatives

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Department of Intensive Care Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
  • UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
  • Department of Psychiatry, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

ORCID-Profile: Thomas G van Gelder

Förderung

  • the Society
  • Chartered Society of Forensic Sciences

Zitieren

APA

van Gelder, T. G., van Diem-Zaal, I. J., Dijkstra-Kersten, S. M. A., de Mul, N., Lalmohamed, A., & Slooter, A. J. C. (2024). The risk of delirium after sedation with propofol or midazolam in intensive care unit patients. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16031

Vancouver

van Gelder TG, van Diem-Zaal IJ, Dijkstra-Kersten SMA, de Mul N, Lalmohamed A, Slooter AJC. The risk of delirium after sedation with propofol or midazolam in intensive care unit patients. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16031

BibTeX
@article{vanGelder2024,
  author = {van Gelder, Thomas G and van Diem-Zaal, Irene J and Dijkstra-Kersten, Sandra M A and de Mul, Nikki and Lalmohamed, Arief and Slooter, Arjen J C},
  title = {The risk of delirium after sedation with propofol or midazolam in intensive care unit patients},
  journal = {British Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1111/bcp.16031}
}
Kostenlos starten →